Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Figure out How to Forestall Tooth Staining - 2Winter virus season so far is not too bad, but doctors worry about suffering to come
- 3The Significance of Prenuptial Arrangements in Separation Procedures
- 4NASA just launched Artemis 2. What happens today could make or break the moon mission
- 5Careful Connections: Building Association and Trust
- Experience Unrivaled Sound: Top Speakers You Really want to Hear
- 9 Under-The-Radar Malaysian Islands To Consider Instead Of Thailand Or Indonesia
- As world leaders enter climate talks, people in poverty have the most at stake
- Clocks to go forward one hour in Europe as summer time starts
- Smuggler who called migrants 'chickens' jailed
- ISS astronaut snaps stunning nighttime photo of Florida and Cuba | Space photo of the day for Dec. 29, 2025
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- They grew up with 'almond moms.' Now, they dread going home for the holidays.
- Changes to CDC website spark debate over autism and vaccine misinformation
